Effect of 4-HPR enhancing anti-cancer efficancy of cisplatin to ovarian cancer
Sun Mi Hong
Abstract
Sun Mi Hong
Abstract
OBJECTIVE:To study the effect of 4-HPR combined with DDP on morphological changes,proliferation,apoptosis and cell cycle of human ovarian cancer SKOV3 cells and its relationship with VEGF and u-PA expressions.METHODS:The effect of 4-HPR on morphological changes of SKOV3 cell was observed by an optical microscope.The effect of 4-HPR and DDP on SKOV3 cell proliferation was measured by MTT assay.The cell apoptosis and cell cycle were analyzed by flow cytometry(FCM).The VEGF and u-PA mRNA expressions of SKOV3 cells were detected by RT-PCR analysis.RESULT:One μmol/L of DDP had weak inhibitory effect on SKOV3 cells,more than 5 μmol/L of DDP had remarkable inhibitory effect on SKOV3 cell(P0.05).One μmol/L of 4-HPR had unconspicuous inhibitory effect on SKOV3 cell,and more than 2.5 μmol/L 4-HPR had distinct inhibitory effect on SKOV3 cell(P0.05).Five μmol/L of DDP combined with 4-HPR(1,5 and 10 μmol/L)significantly inhibited the proliferation of ovarian cancer SKOV3 cells,which had a statistical difference compared with the DDP single medication group(P0.05).4-HPR combined with DDP induced cell apoptosis and arrested SKOV3 cell at G2-M and S stage compared with the control and 4-HPR,DDP used alone groups(P0.05).4-HPR combined with DDP decreased the expressions of VEGF and u-PA mRNA compared with the control and 4-HPR,DDP used alone groups(P0.01).CONCLUSION:4-HPR combined with DDP can significantly inhibit the proliferation,induce apoptosis,and block cell cycle of ovarian cancer SKOV3 cells,which is associated with the VEGF and u-PA expressions.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the effect of 4-HPR combined with DDP on morphological changes,proliferation,apoptosis and cell cycle of human ovarian cancer SKOV3 cells and its relationship with VEGF and u-PA expressions.METHODS:The effect of 4-HPR on morphological changes of SKOV3 cell was observed by an optical microscope.The effect of 4-HPR and DDP on SKOV3 cell proliferation was measured by MTT assay.The cell apoptosis and cell cycle were analyzed by flow cytometry(FCM).The VEGF and u-PA mRNA expressions of SKOV3 cells were detected by RT-PCR analysis.RESULT:One μmol/L of DDP had weak inhibitory effect on SKOV3 cells,more than 5 μmol/L of DDP had remarkable inhibitory effect on SKOV3 cell(P0.05).One μmol/L of 4-HPR had unconspicuous inhibitory effect on SKOV3 cell,and more than 2.5 μmol/L 4-HPR had distinct inhibitory effect on SKOV3 cell(P0.05).Five μmol/L of DDP combined with 4-HPR(1,5 and 10 μmol/L)significantly inhibited the proliferation of ovarian cancer SKOV3 cells,which had a statistical difference compared with the DDP single medication group(P0.05).4-HPR combined with DDP induced cell apoptosis and arrested SKOV3 cell at G2-M and S stage compared with the control and 4-HPR,DDP used alone groups(P0.05).4-HPR combined with DDP decreased the expressions of VEGF and u-PA mRNA compared with the control and 4-HPR,DDP used alone groups(P0.01).CONCLUSION:4-HPR combined with DDP can significantly inhibit the proliferation,induce apoptosis,and block cell cycle of ovarian cancer SKOV3 cells,which is associated with the VEGF and u-PA expressions.
Key concepts: Apoptosis, Cisplatin, Flow cytometry, Cell growth, Cell cycle, Cell, Ovarian cancer, MTT assay